期刊文献+

系统性硬皮病患者血清ENA多肽抗体与临床的关系 被引量:5

Clinical associations based on serum anti-ENA polypeptide antibodies in patients with systemic scleroderma
暂未订购
导出
摘要 分析46例系统性硬皮病(SSc)患者血清ENA(盐水可提取抗原)多肽抗体与临床的关系。结果表明ENA多肽抗体中 ,抗Scl 70抗体与肺间质纤维化紧密相关 ,检测SSc患者抗Scl 70抗体有助于估计其器官累及情况。早期不发生器官累及的皮肤弥漫型系统性硬皮病(dcSSc)可称为慢性dcSSc。 The clinical associations with anti ENA polypeptide antibodies in the sera of 46 patients with systemic scleroderma(SSc) were analyzed. The results showed that anti Scl 70 antibody of anti ENA poplypeptide antibodies was closely associated with pulmonary interstitial fibrosis, the determination of anti Scl 70 antibody in SSc patients might be helpful for evaluating organ involvement in these patients. Some diffuse cutaneous SSc(dcSSc) who did not develop organ involvement in early stage could be called chronic dcSSc.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2000年第1期16-17,共2页 Journal of Clinical Dermatology
关键词 硬皮病 系统性 ENA-多肽抗体 抗Scl-70抗体 Scleroderma,systemic Anti ENA polypeptide antibodies Anti Scl 70 antibody
  • 相关文献

参考文献4

二级参考文献1

  • 1T. Wetzig,J. B. Petri,M. Mittag,U.-F. Haustein. Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis[J] 1998,Archives of Dermatological Research(4):187~190

共引文献13

同被引文献26

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部